Literature DB >> 31375930

Investigating Maternal Brain Alterations in Preeclampsia: the Need for a Multidisciplinary Effort.

Lina Bergman1,2, Pablo Torres-Vergara3,4, Jeffrey Penny5, Johan Wikström6, Maria Nelander7, Jose Leon4,8, Mary Tolcher7, James M Roberts9, Anna-Karin Wikström7, Carlos Escudero10,11.   

Abstract

PURPOSE OF REVIEW: To provide insight into the mechanisms underlying cerebral pathophysiology and to highlight possible methods for evaluation, screening, and surveillance of cerebral complications in preeclampsia. RECENT
FINDINGS: The pathophysiology of eclampsia remains enigmatic. Animal studies show that the cerebral circulation in pregnancy and preeclampsia might be affected with increased permeability over the blood-brain barrier and altered cerebral blood flow due to impaired cerebral autoregulation. The increased blood pressure cannot be the only underlying cause of eclampsia and cerebral edema, since some cases of eclampsia arise without simultaneous hypertension. Findings from animal studies need to be confirmed in human tissues. Evaluation of brain alterations in preeclampsia and eclampsia is challenging and demands a multidisciplinary collaboration, since no single method can accurately and fully describe how preeclampsia affects the brain. Cerebral complications of preeclampsia are significant factors in maternal morbidity and mortality worldwide. No single method can accurately describe the full picture of how preeclampsia affects the brain vasculature and parenchyma. We recommend an international and multidisciplinary effort not only to overcome the issue of limited sample availability but also to optimize the quality of research.

Entities:  

Keywords:  Biomarkers; Blood-brain barrier; Brain complications; Brain imaging; Eclampsia; Preclinical studies; Preeclampsia

Mesh:

Year:  2019        PMID: 31375930     DOI: 10.1007/s11906-019-0977-0

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  96 in total

1.  Serum S100B in pregnancy-related hypertensive disorders: a case-control study.

Authors:  Adriana P Schmidt; Adriano B L Tort; Olavo B Amaral; André P Schmidt; Roger Walz; Janete Vettorazzi-Stuckzynski; Sérgio H Martins-Costa; José Geraldo L Ramos; Diogo O Souza; Luis V C Portela
Journal:  Clin Chem       Date:  2004-02       Impact factor: 8.327

Review 2.  Evidence for bulk flow of brain interstitial fluid: significance for physiology and pathology.

Authors:  N Joan Abbott
Journal:  Neurochem Int       Date:  2004-09       Impact factor: 3.921

3.  Change in estimated cerebral perfusion pressure after treatment with nimodipine or magnesium sulfate in patients with preeclampsia.

Authors:  M A Belfort; G R Saade; M Yared; C Grunewald; J A Herd; M A Varner; H Nisell
Journal:  Am J Obstet Gynecol       Date:  1999-08       Impact factor: 8.661

Review 4.  The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP).

Authors:  M A Brown; M D Lindheimer; M de Swiet; A Van Assche; J M Moutquin
Journal:  Hypertens Pregnancy       Date:  2001       Impact factor: 2.108

5.  Cerebral perfusion pressure, and not cerebral blood flow, may be the critical determinant of intracranial injury in preeclampsia: a new hypothesis.

Authors:  Michael A Belfort; Michael W Varner; Donna S Dizon-Townson; Charlotta Grunewald; Henry Nisell
Journal:  Am J Obstet Gynecol       Date:  2002-09       Impact factor: 8.661

6.  Magnetic resonance spectroscopy in pre-eclampsia: evidence of cerebral ischaemia.

Authors:  Jane M Rutherford; Alan Moody; Sarah Crawshaw; Peter C Rubin
Journal:  BJOG       Date:  2003-04       Impact factor: 6.531

7.  Serum S100beta: a noninvasive marker of blood-brain barrier function and brain lesions.

Authors:  Andrew A Kanner; Nicola Marchi; Vincent Fazio; Marc R Mayberg; Michael T Koltz; Vitaly Siomin; Glen H J Stevens; Thomas Masaryk; Barbara Aumayr; Barbara Ayumar; Michael A Vogelbaum; Gene H Barnett; Damir Janigro
Journal:  Cancer       Date:  2003-06-01       Impact factor: 6.860

8.  Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial.

Authors:  Douglas Altman; Guillermo Carroli; Lelia Duley; Barbara Farrell; Jack Moodley; James Neilson; David Smith
Journal:  Lancet       Date:  2002-06-01       Impact factor: 79.321

9.  Labetalol decreases cerebral perfusion pressure without negatively affecting cerebral blood flow in hypertensive gravidas.

Authors:  Michael A Belfort; Cathy Tooke-Miller; John C Allen; Donna Dizon-Townson; Michael A Varner
Journal:  Hypertens Pregnancy       Date:  2002       Impact factor: 2.108

Review 10.  Peripheral markers of blood-brain barrier damage.

Authors:  Nicola Marchi; Marco Cavaglia; Vincent Fazio; Sunil Bhudia; Kerri Hallene; Damir Janigro
Journal:  Clin Chim Acta       Date:  2004-04       Impact factor: 3.786

View more
  4 in total

1.  Clinical and Imaging Data-Based Model for Predicting Reversible Posterior Leukoencephalopathy Syndrome (RPLS) in Pregnant Women With Severe Preeclampsia or Eclampsia and Analysis of Perinatal Outcomes.

Authors:  Peng An; Junyan Zhang; Yang Li; Peng Duan; Yan Hu; Xiumei Li; Zhongqiu Wang
Journal:  Int J Clin Pract       Date:  2022-04-15       Impact factor: 3.149

2.  PROVE-Pre-Eclampsia Obstetric Adverse Events: Establishment of a Biobank and Database for Pre-Eclampsia.

Authors:  Lina Bergman; Karl Bergman; Eduard Langenegger; Ashley Moodley; Stephanie Griffith-Richards; Johan Wikström; David Hall; Lloyd Joubert; Philip Herbst; Sonja Schell; Teelkien van Veen; Michael Belfort; Stephen Y C Tong; Susan Walker; Roxanne Hastie; Catherine Cluver
Journal:  Cells       Date:  2021-04-20       Impact factor: 6.600

3.  Unaffected Memory and Inhibitory Functioning Several Weeks Postpartum in Women with Pregnancy Complicated by Preeclampsia.

Authors:  Ilona Papousek; Elisabeth M Weiss; Manfred G Moertl; Karin Schmid-Zalaudek; Edina Krenn; Verena Lessiak; Helmut K Lackner
Journal:  Behav Sci (Basel)       Date:  2021-04-18

4.  Cerebrospinal beta-amyloid peptides(1-40) and (1-42) in severe preeclampsia and HELLP syndrome - a pilot study.

Authors:  Wolfgang Lederer; Cristina Alomar-Dominguez; Christian Humpel; Helene Schaffenrath; Julia Thaler; Raffaella Fantin; Lucie Dostal; Guenther Putz
Journal:  Sci Rep       Date:  2020-04-01       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.